Innate Pharma S.a. sell Lokrim
Start price
22.01.24
/
20%
€2.40
Target price
22.01.25
-
Performance (%)
-8.33%
Price
14.05.24
€2.20
Summary
This prediction is currently active. With a performance of -8.33%, the SELL prediction for Innate Pharma S.a. by Lokrim is down slightly. This prediction currently runs until 22.01.25. The prediction end date can be changed by Lokrim at any time. Lokrim has 20% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Innate Pharma S.a. | - | - |
| iShares Core DAX® | 1.662% | 4.835% |
| iShares Nasdaq 100 | 0.667% | 0.000% |
| iShares Nikkei 225® | -2.139% | -4.786% |
| iShares S&P 500 | 0.564% | 0.775% |
According to Lokrim what are the pros and cons of Innate Pharma S.a. for the foreseeable future?
Pros
Cons
Probably not worthwhile Investment
Comments by Lokrim for this prediction
In the thread Innate Pharma S.a. diskutieren
Sell Innate Pharma S.a.